MarketCap
Eton Pharmaceuticals ETON
€ 61.75
1.33%
Facebook
X
Telegram
Eton Pharmaceuticals ROA | ETON
ROA Jährlich Eton Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.99 | -5.02 | -2.95 | -36.04 | -7.12 | -106.27 | -107.31 | -44.97 | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.95 | -107.31 | -39.34 |
ROA Vierteljährlich Eton Pharmaceuticals
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.61 | 11.35 | -1.19 | -4.65 | -7.04 | -3.45 | -10.46 | -11.23 | -17.55 | -21.13 | 3.16 | -5.32 | 5.43 | -6.88 | -28.38 | -40.24 | -40.11 | -48.86 | -48.84 | -9.46 | -42.45 | -76.62 | -102.37 | -171.26 | -157.84 | -137.52 | -122.84 | -102.55 | -178.77 | -190.37 | -183.44 | -161.9 | -90.74 | -10.88 | -10.65 | - | -20.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 35.61 | -190.37 | -55.84 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
BiomX
PHGE
|
-625.96 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-70.04 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-137.13 | - | - | $ 301 M |  USA |
 |
Pluristem Therapeutics
PSTI
|
-95.75 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-54.24 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-4.6 | - | -6.08 % | $ 184 M |  China |
 |
Cassava Sciences
SAVA
|
-76.86 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-43.96 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
-205.76 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-113.22 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-92.07 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-107.57 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-62.08 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-6.51 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-37.99 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-137.96 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
2.88 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
11.63 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-47.98 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
-198.56 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-6.41 | - | - | $ 26.8 M | USA |
 |
Trean Insurance Group
TIG
|
-4.17 | - | - | $ 316 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-79.54 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-166.66 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-98.29 | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
-80.09 | - | - | $ 24.9 M | USA |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Therapeutics
APLT
|
-121.84 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-22.28 | - | - | $ 8.86 M | Canada |
 |
Generation Bio Co.
GBIO
|
-56.95 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-136.72 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-27.51 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-54.04 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-74.47 | $ 4.2 | -0.36 % | $ 651 M | USA |
 |
AbbVie
ABBV
|
1.36 | $ 294.72 | 0.32 % | $ 521 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
-55.34 | $ 4.63 | 21.05 % | $ 20 M | Israel |
 |
Avenue Therapeutics
ATXI
|
-99.25 | - | -52.27 % | $ 4.45 M | USA |
 |
Achieve Life Sciences
ACHV
|
-130.77 | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Axon Enterprise
AXON
|
1.78 | $ 316.97 | 4.77 % | $ 24.7 B | USA |
|
TFF Pharmaceuticals
TFFP
|
-176.62 | - | -60.05 % | $ 125 K | USA |
 |
Bristol-Myers Squibb Company
BMY
|
7.83 | $ 62.89 | 0.18 % | $ 128 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-28.79 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Axcella Health
AXLA
|
-428.94 | - | -16.42 % | $ 249 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
-55.1 | $ 58.59 | 4.29 % | $ 7.04 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.77 | - | - | $ 2.02 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
6.32 | $ 159.75 | 5.35 % | $ 20.9 B | USA |